Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

Ponzo, M; Debesset, A; Cossutta, M; Chalabi-Dchar, M; Houppe, C; Pilon, C; Nicolas-Boluda, A; Meunier, S; Raineri, F; Thiolat, A; Nicolle, R; Maione, F; Brundu, S; Cojocaru, CF; Bouvet, P; Bousquet, C; Gazeau, F; Tournigand, C; Courty, J; Giraudo, E; Cohen, JL; Cascone, I

Cascone, I (通讯作者)，IMRB Univ Paris Est Creteil UPEC 8, IMRB, INSERM, Immune Regulat & Biotherapy,Inserm U955, F-94010 Creteil, France.;Cascone, I (通讯作者)，Grp Hosp Univ Chenevier Mondor, AP HP, Ctr Invest Clin Biotherapie, F-94010 Creteil, France.

CANCERS, 2022; 14 (17):

Abstract

Simple Summary Nucleolin (NCL) regulates tumour growth and angiogenesis, and its inhibition normalizes tumour vessels and impairs pancreatic ductal ad......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索